1. Home
  2. AEVAW vs SNOA Comparison

AEVAW vs SNOA Comparison

Compare AEVAW & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEVAW
  • SNOA
  • Stock Information
  • Founded
  • AEVAW N/A
  • SNOA 1999
  • Country
  • AEVAW United States
  • SNOA United States
  • Employees
  • AEVAW N/A
  • SNOA N/A
  • Industry
  • AEVAW Auto Parts:O.E.M.
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEVAW Consumer Discretionary
  • SNOA Health Care
  • Exchange
  • AEVAW Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • AEVAW 4.0M
  • SNOA 3.6M
  • IPO Year
  • AEVAW N/A
  • SNOA 2007
  • Fundamental
  • Price
  • AEVAW $0.07
  • SNOA $2.40
  • Analyst Decision
  • AEVAW
  • SNOA
  • Analyst Count
  • AEVAW 0
  • SNOA 0
  • Target Price
  • AEVAW N/A
  • SNOA N/A
  • AVG Volume (30 Days)
  • AEVAW N/A
  • SNOA 52.9K
  • Earning Date
  • AEVAW N/A
  • SNOA 02-05-2025
  • Dividend Yield
  • AEVAW N/A
  • SNOA N/A
  • EPS Growth
  • AEVAW N/A
  • SNOA N/A
  • EPS
  • AEVAW N/A
  • SNOA N/A
  • Revenue
  • AEVAW N/A
  • SNOA $13,973,000.00
  • Revenue This Year
  • AEVAW N/A
  • SNOA $23.89
  • Revenue Next Year
  • AEVAW N/A
  • SNOA $25.45
  • P/E Ratio
  • AEVAW N/A
  • SNOA N/A
  • Revenue Growth
  • AEVAW N/A
  • SNOA 13.51
  • 52 Week Low
  • AEVAW N/A
  • SNOA $2.30
  • 52 Week High
  • AEVAW N/A
  • SNOA $9.40
  • Technical
  • Relative Strength Index (RSI)
  • AEVAW N/A
  • SNOA 36.06
  • Support Level
  • AEVAW N/A
  • SNOA $2.30
  • Resistance Level
  • AEVAW N/A
  • SNOA $2.62
  • Average True Range (ATR)
  • AEVAW 0.00
  • SNOA 0.12
  • MACD
  • AEVAW 0.00
  • SNOA -0.02
  • Stochastic Oscillator
  • AEVAW 0.00
  • SNOA 21.59

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: